Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willerson

Showing results (611-620 of 797) with videos related to

Pageof 80
Sort By:
Science Signaling|May 7, 2015
Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient miceYuka Morikawa, Min Zhang, Todd Heallen, et al.
Circulation Research|March 10, 2007
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathyAdriana Osio, Lily Tan, Suet N Chen, et al.
Journal of the American College of Cardiology|September 1, 1990
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variationsS K Yao, M Rosolowsky, H V Anderson, et al.
Circulation Research|April 11, 2009
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathyRaffaella Lombardi, Jinjiang Dong, Gabriela Rodriguez, et al.
Circulation|September 1, 1981
The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarctionJ R Corbett, G J Dehmer, S E Lewis, et al.
Circulation|April 1, 1989
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosisP Golino, J H Ashton, J McNatt, et al.
Nature|October 5, 2017
Hippo pathway deficiency reverses systolic heart failure after infarctionJohn P Leach, Todd Heallen, Min Zhang, et al.
Texas Medicine|July 1, 1981
Thallium 201 myocardial scintigraphy and exercise testing in patients prior to and following coronary artery revascularizationJ Ormand, R W Parkey, M R Platt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injuryJ T Willerson, S K Yao, J McNatt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1983
A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chlorideC Izquierdo, M D Devous, P Nicod, et al.
Pageof 80

Showing results (611-620 of 797) with videos related to

Sort By:
Pageof 80
Science Signaling|May 7, 2015
Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient miceYuka Morikawa, Min Zhang, Todd Heallen, et al.
Circulation Research|March 10, 2007
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathyAdriana Osio, Lily Tan, Suet N Chen, et al.
Journal of the American College of Cardiology|September 1, 1990
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variationsS K Yao, M Rosolowsky, H V Anderson, et al.
Circulation Research|April 11, 2009
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathyRaffaella Lombardi, Jinjiang Dong, Gabriela Rodriguez, et al.
Circulation|September 1, 1981
The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarctionJ R Corbett, G J Dehmer, S E Lewis, et al.
Circulation|April 1, 1989
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosisP Golino, J H Ashton, J McNatt, et al.
Nature|October 5, 2017
Hippo pathway deficiency reverses systolic heart failure after infarctionJohn P Leach, Todd Heallen, Min Zhang, et al.
Texas Medicine|July 1, 1981
Thallium 201 myocardial scintigraphy and exercise testing in patients prior to and following coronary artery revascularizationJ Ormand, R W Parkey, M R Platt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injuryJ T Willerson, S K Yao, J McNatt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1983
A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chlorideC Izquierdo, M D Devous, P Nicod, et al.
Pageof 80